Protagonist Therapeutics, Inc. - Laporan Laba Rugi (TTM)

Protagonist Therapeutics, Inc.
US ˙ NasdaqGM ˙ US74366E1029

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Protagonist Therapeutics, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 26 29 31 27 24 27 47 45 35 27 1 0 0 60 315 319 324 434 208 209
Change (%) 11.41 8.88 -12.68 -10.39 12.16 71.40 -3.00 -22.61 -24.48 -96.77 -100.00 NaN 424.92 1.32 1.46 34.17 -52.17 0.66
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales
Change (%)
% of Revenue
Gross Operating Profit 26 29 31 27 24 27 47 45 35 27 1 0 0 60 315 319 324 434 208 209
Change (%) 11.41 8.88 -12.68 -10.39 12.16 71.40 -3.00 -22.61 -24.48 -96.77 -100.00 NaN 424.92 1.32 1.46 34.17 -52.17 0.66
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
SG&A 18 19 20 23 25 27 32 33 32 32 30 31 32 33 40 40 43 43 40 41
Change (%) 5.00 7.45 12.67 10.48 9.09 16.73 3.07 -1.08 -1.94 -6.02 4.96 2.43 4.43 18.83 0.67 6.23 2.12 -7.30 2.76
% of Revenue 69.08 65.10 64.25 82.90 102.21 99.41 67.70 71.94 91.96 119.40 3,472.53 55.82 12.64 12.55 13.14 10.00 19.39 19.79
R&D 71 75 80 86 107 126 138 146 135 126 117 116 121 120 126 127 132 138 140 144
Change (%) 5.04 7.35 7.72 24.33 17.63 9.58 5.92 -7.90 -6.30 -7.05 -1.22 4.54 -0.81 5.26 0.27 4.18 4.55 1.56 2.51
% of Revenue 276.03 260.26 256.60 316.55 439.19 460.60 294.47 321.56 382.70 474.83 13,656.93 200.27 40.16 39.74 40.80 31.80 67.51 68.75
OpEx 89 93 100 109 132 153 170 179 167 158 147 147 153 154 166 167 175 182 181 185
Change (%) 5.03 7.37 8.71 21.45 16.02 10.85 5.39 -6.65 -5.46 -6.85 0.04 4.09 0.28 8.22 0.36 4.68 3.95 -0.56 2.56
% of Revenue 345.11 325.36 320.85 399.45 541.41 560.01 362.18 393.50 474.66 594.24 17,129.45 256.09 52.79 52.29 53.95 41.80 86.90 88.54
Operating Income -63 -65 -69 -82 -108 -126 -123 -133 -132 -131 -146 -147 -153 -94 149 152 149 253 27 24
Change (%) 2.43 6.70 18.40 32.09 16.89 -2.31 8.59 -1.22 -0.38 11.35 0.62 4.09 -38.88 -258.76 2.40 -2.05 69.57 -89.23 -11.93
% of Revenue -245.11 -225.36 -220.85 -299.45 -441.41 -460.01 -262.18 -293.50 -374.66 -494.24 -17,029.45 -156.09 47.21 47.71 46.05 58.20 13.10 11.46
Interest Expense -1 -1 -0 -0 -0
Change (%) -6.56 -40.64 -58.87 -13.01
% of Revenue -2.49 -2.09 -1.14 -0.54 -0.52
Net Income -65 -66 -70 -81 -108 -126 -122 -133 -130 -127 -140 -138 -140 -79 162 170 171 275 56 52
Change (%) 2.14 5.92 16.30 31.96 16.76 -2.44 8.32 -1.94 -2.09 10.04 -1.84 2.09 -43.80 -305.32 4.84 0.53 61.07 -79.58 -7.39
% of Revenue -252.03 -231.07 -224.79 -299.39 -440.88 -458.94 -261.21 -291.70 -369.64 -479.26 -16,319.91 -131.59 51.47 53.26 52.76 63.34 27.04 24.88

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista